Abstract
Purpose
In the present study, a case of repeated intravitreal dexamethasone implantation for a suspected idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) syndrome associated with recurrent exudative retinal detachment and macular edema is reported.
Case summary
A 39-year-old female who underwent steroid pulse therapy due to Vogt-Koyanagi-Harada disease in the left eye was referred for exudative retinal detachment and macular edema. Best corrected visual acuity (BCVA) was 1.0 in the right eye and 0.5 in the left eye. Cystoid macular edema combined with serous retinal detachment was observed on spectraldomain optical coherence tomography. Fluorescein angiography revealed neovascularization and multiple macroaneurysms with fluorescein leakage in the left peripapillary area. Severe peripheral capillary non-perfusion and fluorescein leakage were also observed in both eyes. Intravitreal dexamethasone implantation was performed in the left eye and macular edema showed wax-and-wane pattern. No edema was observed after 4 additional dexamethasone implantations, however, preretinal hemorrhage occurred in the peripapillary area during treatment. Seventeen months after initiation of treatment, BCVA was 0.6 in the left eye and dry macula was maintained.
References
1. Chang TS, Aylward GW, Davis JL, et al. Idiopathic retinal abdominal, aneurysms, and abdominal. Retinal Vasculitis Study. Ophthalmology. 1995; 102:1089–97.
2. DiLoreto DA Jr, Sadda SR. Idiopathic retinal vasculitis, abdominal, and neuroretinitis (IRVAN) with preserved perfusion. Retina. 2003; 23:554–7.
3. Pichi F, Ciardella AP. Imaging in the diagnosis and management of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN). Int Ophthalmol Clin. 2012; 52:275–82.
4. Samuel MA, Equi RA, Chang TS, et al. Idiopathic retinitis, abdominal, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology. 2007; 114:1526–9.e1.
5. Tomita M, Matsubara T, Yamada H, et al. Long term follow up in a case of successfully treated idiopathic retinal vasculitis, abdominal, and neuroretinitis (IRVAN). Br J Ophthalmol. 2004; 88:302–3.
6. Karagiannis D, Soumplis V, Georgalas I, Kandarakis A. Ranibizumab for idiopathic retinal vasculitis, aneurysms, and abdominal: favorable results. Eur J Ophthalmol. 2010; 20:792–4.
7. Empeslidis T, Banerjee S, Vardarinos A, Konstas AG. Dexamethasone intravitreal implant for idiopathic retinal vasculitis, abdominal, and neuroretinitis. Eur J Ophthalmol. 2013; 23:757–60.
8. Saatci AO, Ayhan Z, Takeş Ö, et al. Single bilateral dexamethasone implant in addition to panretinal photocoagulation and oral abdominal treatment in IRVAN syndrome. Case Rep Ophthalmol. 2015; 6:56–62.
9. Moon SJ, Misch DM. Intravitreal bevacizumab for macular edema from idiopathic retinal vasculitis, aneurysms, and neuroretinitis. Ophthalmic Surg Lasers Imaging. 2010; Mar 9:1–3. doi:. DOI: 10.3928/15428877-20100216-10. [Epub ahead of print].
10. Owens SL, Gregor ZJ. Vanishing retinal arterial aneurysms: a case report. Br J Ophthalmol. 1992; 76:637–8.
11. Gedik S, Yilmaz G, Akça S, Akova YA. An atypical case of abdominal retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome. Eye (Lond). 2005; 19:469–71.
12. Venkatesh P, Verghese M, Davde M, Garg S. Primary vascular abdominal in IRVAN (idiopathic retinal vasculitis, aneurysms, abdominal) syndrome. Ocul Immunol Inflamm. 2006; 14:195–6.
13. Cheema RA, Al-Askar E, Cheema HR. Infliximab therapy for abdominal retinal vasculitis, aneurysm, and neuroretinitis syndrome. J Ocul Pharmacol Ther. 2011; 27:407–10.
14. Yeshurun I, Recillas-Gispert C, Navarro-Lopez P, et al. Extensive dynamics in location, shape, and size of aneurysms in a patient with idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis. Am J Ophthalmol. 2003; 135:118–20.